Deficiency of the transcription factor GATA2 is a highly penetrant genetic disorder predisposing to myelodysplastic syndromes (MDS) and immunodeficiency. It has been recognized as the most common cause underlying primary MDS in children. Triggered by the discovery of a recurrent synonymous GATA2 variant, we systematically investigated 911 patients with phenotype of pediatric MDS or cellular deficiencies for the presence of synonymous alterations in GATA2. In total, we identified nine individuals with five heterozygous synonymous mutations: c.351C>G, p.T117T (N = 4); c.649C>T, p.L217L; c.981G>A, p.G327G; c.1023C>T, p.A341A; and c.1416G>A, p.P472P (N = 2). They accounted for 8.2% (9/110) of cases with GATA2 deficiency in our cohort and resulted in selective loss of mutant RNA. While for the hotspot mutation (c.351C>G) a splicing error leading to RNA and protein reduction was identified, severe, likely late stage RNA loss without splicing disruption was found for other mutations. Finally, the synonymous mutations did not alter protein function or stability. In summary, synonymous GATA2 substitutions are a new common cause of GATA2 deficiency. These findings have broad implications for genetic counseling and pathogenic variant discovery in Mendelian disorders.

Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency / Kozyra, E. J.; Pastor, V. B.; Lefkopoulos, S.; Sahoo, S. S.; Busch, H.; Voss, R. K.; Erlacher, M.; Lebrecht, D.; Szvetnik, E. A.; Hirabayashi, S.; Pasauliene, R.; Pedace, L.; Tartaglia, M.; Klemann, C.; Metzger, P.; Boerries, M.; Catala, A.; Hasle, H.; de Haas, V.; Kallay, K.; Masetti, R.; De Moerloose, B.; Dworzak, M.; Schmugge, M.; Smith, O.; Stary, J.; Mejstrikova, E.; Ussowicz, M.; Morris, E.; Singh, P.; Collin, M.; Derecka, M.; Gohring, G.; Flotho, C.; Strahm, B.; Locatelli, F.; Niemeyer, C. M.; Trompouki, E.; Wlodarski, M. W.. - In: LEUKEMIA. - ISSN 0887-6924. - 34:10(2020), pp. 2673-2687. [10.1038/s41375-020-0899-5]

Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency

Locatelli F.;
2020

Abstract

Deficiency of the transcription factor GATA2 is a highly penetrant genetic disorder predisposing to myelodysplastic syndromes (MDS) and immunodeficiency. It has been recognized as the most common cause underlying primary MDS in children. Triggered by the discovery of a recurrent synonymous GATA2 variant, we systematically investigated 911 patients with phenotype of pediatric MDS or cellular deficiencies for the presence of synonymous alterations in GATA2. In total, we identified nine individuals with five heterozygous synonymous mutations: c.351C>G, p.T117T (N = 4); c.649C>T, p.L217L; c.981G>A, p.G327G; c.1023C>T, p.A341A; and c.1416G>A, p.P472P (N = 2). They accounted for 8.2% (9/110) of cases with GATA2 deficiency in our cohort and resulted in selective loss of mutant RNA. While for the hotspot mutation (c.351C>G) a splicing error leading to RNA and protein reduction was identified, severe, likely late stage RNA loss without splicing disruption was found for other mutations. Finally, the synonymous mutations did not alter protein function or stability. In summary, synonymous GATA2 substitutions are a new common cause of GATA2 deficiency. These findings have broad implications for genetic counseling and pathogenic variant discovery in Mendelian disorders.
2020
GATA2; RNA; MDS
01 Pubblicazione su rivista::01a Articolo in rivista
Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency / Kozyra, E. J.; Pastor, V. B.; Lefkopoulos, S.; Sahoo, S. S.; Busch, H.; Voss, R. K.; Erlacher, M.; Lebrecht, D.; Szvetnik, E. A.; Hirabayashi, S.; Pasauliene, R.; Pedace, L.; Tartaglia, M.; Klemann, C.; Metzger, P.; Boerries, M.; Catala, A.; Hasle, H.; de Haas, V.; Kallay, K.; Masetti, R.; De Moerloose, B.; Dworzak, M.; Schmugge, M.; Smith, O.; Stary, J.; Mejstrikova, E.; Ussowicz, M.; Morris, E.; Singh, P.; Collin, M.; Derecka, M.; Gohring, G.; Flotho, C.; Strahm, B.; Locatelli, F.; Niemeyer, C. M.; Trompouki, E.; Wlodarski, M. W.. - In: LEUKEMIA. - ISSN 0887-6924. - 34:10(2020), pp. 2673-2687. [10.1038/s41375-020-0899-5]
File allegati a questo prodotto
File Dimensione Formato  
Kozyra_Synonymous_2020.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 2.05 MB
Formato Adobe PDF
2.05 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1480445
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 29
social impact